Trials / Completed
CompletedNCT01431066
ActiPatch Plantar Fasciitis Clinical Trial
Continuous Low Energy Pulsed Radio Frequency Electromagnetic Field Therapy for the Treatment of Plantar Fasciopathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Plantar fasciopathy is a chronic condition affecting both sedentary populations, individuals in the workplace who must stand for prolonged periods of time, and athletes. It can be disabling. There is no single accepted treatment course that is recommended in the literature. The use of pulsed radio-frequency electromagnetic (PRFE) devices has been proposed as a treatment option in chronic soft-tissue injury due to its ability to reduce pain and inflammation. The proposed study will investigate the efficacy of the use of a PRFE device for the treatment of chronic heel pain using a double blind randomized placebo controlled design study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sham pulsed radio-frequency electromagnetic device | Disabled PRFE device |
| DEVICE | ActiPatch PRFE Device | Actipatch PRFE device |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2011-09-09
- Last updated
- 2014-03-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01431066. Inclusion in this directory is not an endorsement.